FBIO

Fortress Biotech Inc.

Price

$2.80

return (12m)

15.70%

p/e

0.66

p/bv

0.45

DIVIDEND YIELD

0.00%

FBIO price

Fortress Biotech

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment FBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-18.60%

3 months

0.00%

1 year

15.70%

2 years

37.25%

5 years

-42.56%

10 years

-31.62%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals FBIO

Valuation

P/E

0.66

Sector -4.26

Industry -4.26

P/BV

0.45

Sector 2.11

Industry 2.11

P/Revenue (PSR)

1.79

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

0.30

Sector 1.25

Industry 1.25

P/Net Current Assets

0.70

Sector -5.47

Industry -5.47

P/Working Capital

0.51

Sector -1.10

Industry -1.10

EPS

4.41

Sector -1.94

Industry -1.94

BVPS

6.44

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

65.41%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-55.70%

Sector -36.74%

Industry -36.74%

Net Profit Margins

100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.06

Sector 0.03

Industry 0.03

Profitability

ROE

68.51%

Sector -61.50%

Industry -61.50%

ROA

44.58%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.96

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.17

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.17

Sector -0.83

Industry -0.83

Equity/Assets

0.65

Sector 0.43

Industry 0.43

Liabilities/Assets

0.35

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-5.30%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Fortress Biotech ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$2.80

Fair Value

$25.28

Upside Return potential.

802.81%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals FBIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
FBIO Fortress Biotech Inc.	$2.80	19.15%	0.00%	0.66	0.45	68.51%	100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

FBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Fortress Biotech

Fortress Biotech Inc.

Average Investor10 user rating

4.0 (3 people)

United States

20 years

Founded: 2006

2011

Time since IPO - 15 years

111

Employees

Fortress Biotech Inc. (United States) is listed on the Nasdaq and has a market capitalization of $93.76 million, with shareholders equity totaling $206.09 million.

The company employs approximately 111 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Fortress Biotech Inc. reported $52.39 million in revenue, generating net income of $141.19 million.

Key financial metrics include a P/E ratio of 0.66, a price-to-book (P/B) ratio of 0.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker FBIO.

Market cap

$93.76 million

Net worth

$206.09 million

$206,090,000.00

Assets

$316.71 million

$316,710,000.00

Total Shares Outstanding

32.00 million

32,000,000

Average Daily Trading Volume

$648.84 Thousand

$648,841.64

Sector

Health Care

Industry

Biotechnology

FBIO

FBIO revenue and profits

Financial Results FBIO

DRAG THE FRAME TO SEE MORE DATA

FBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Fortress Biotech (FBIO) today?

A cotação de Fortress Biotech (FBIO) hoje está em US$ 2.80, com uma variação de 15.7% em relação ao último ano. A cotação de Fortress Biotech (FBIO) iniciou o ano negociando na casa dos US$ 3.66 e hoje está em US$ 2.80. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Fortress Biotech (FBIO) e dados de ações do Ibovespa e mercados internacionais.

Quando Fortress Biotech (FBIO) paga dividendos?

Fortress Biotech (FBIO) não distribuiu dividendos no último ano.

Is Fortress Biotech (FBIO) a good investment?

Atualmente, Fortress Biotech (FBIO) está cotada a US$ 2.80, com um P/L de 0.66, representando um desvio de -151% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 15.7 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 15.70%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Fortress Biotech (FBIO) stock?

Investir em ações de Fortress Biotech (FBIO) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Fortress Biotech (FBIO) yield today?

A rentabilidade de Fortress Biotech (FBIO) foi de -18.60% no último mês, 15.70% no último ano e -42.56% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Fortress Biotech (FBIO) hoje, o investimento total seria de US$ 280.00, com base na cotação atual de US$ 2.80.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 323.96
Em 5 anos: US$ 160.83
Em 10 anos: US$ 191.46

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

FBIO

Fortress Biotech Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment FBIO

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING FBIO WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Fortress Biotech

Fortress Biotech Inc.

United States

20 years

2011

111

PROFIT X PRICE FBIO

Financial Results FBIO

FBIO cash flow

Asset, Revenue and Profit Growth - FBIO

FBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions